.webp)
Share
John P. Landino
Healogics, a leading provider of advanced wound care and hyperbaric oxygen therapy services in the United States, has appointed John P. Landino as Chief Development Officer.
The appointment reflects the company’s continued focus on strategic growth and strengthening partnerships across the healthcare ecosystem.
Landino brings nearly two decades of experience in business development, with a strong track record of building and expanding relationships with hospital executives, physicians, and healthcare leaders. His expertise lies in identifying growth opportunities, driving strategic collaborations, and supporting scalable business expansion in complex healthcare environments.
Prior to joining Healogics, Landino held key leadership roles at Fresenius Medical Care North America and Tenet Healthcare. In these positions, he played a significant role in advancing business development strategies, enhancing physician engagement, and supporting the expansion of healthcare services across multiple markets.
In his new role at Healogics, Landino will lead the company’s development strategy, focusing on expanding partnerships and identifying new business opportunities that align with its mission to improve patient outcomes. He will work closely with healthcare providers and systems to extend access to advanced wound care solutions and drive sustainable organizational growth.
His appointment comes at a milestone moment for Healogics as the company celebrates 30 years of delivering specialized wound care services. As the organization looks ahead, Landino’s leadership is expected to play a critical role in shaping its next phase of growth and innovation.
